Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,952 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of lesion calcification on angiographic outcomes after Absorb everolimus-eluting bioresorbable vascular scaffold implantation: an observation from the ABSORB Japan trial.
Ohya M, Kadota K, Sotomi Y, Kozuma K, Tanabe K, Uematsu M, Kawasaki T, Morino Y, Tobaru T, Nakao K, Tachibana K, Kishi K, Shibata Y, Ying S, Kusano H, Stone GW, Popma JJ, Onuma Y, Serruys PW, Kimura T. Ohya M, et al. Among authors: kishi k. EuroIntervention. 2017 Feb 20;12(14):1738-1746. doi: 10.4244/EIJ-D-16-00359. EuroIntervention. 2017. PMID: 27821375 Free article. Clinical Trial.
Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation.
Kimura T, Morimoto T, Nakagawa Y, Tamura T, Kadota K, Yasumoto H, Nishikawa H, Hiasa Y, Muramatsu T, Meguro T, Inoue N, Honda H, Hayashi Y, Miyazaki S, Oshima S, Honda T, Shiode N, Namura M, Sone T, Nobuyoshi M, Kita T, Mitsudo K; j-Cypher Registry Investigators. Kimura T, et al. Circulation. 2009 Feb 24;119(7):987-95. doi: 10.1161/CIRCULATIONAHA.108.808311. Epub 2009 Feb 9. Circulation. 2009. PMID: 19204304
Sirolimus-eluting stent versus balloon angioplasty for sirolimus-eluting stent restenosis: Insights from the j-Cypher Registry.
Abe M, Kimura T, Morimoto T, Taniguchi T, Yamanaka F, Nakao K, Yagi N, Kokubu N, Kasahara Y, Kataoka Y, Otsuka Y, Kawamura A, Miyazaki S, Nakao K, Horiuchi K, Ito A, Hoshizaki H, Kawaguchi R, Setoguchi M, Inada T, Kishi K, Sakamoto H, Morioka N, Imai M, Shiomi H, Nonogi H, Mitsudo K; j-Cypher Registry Investigators. Abe M, et al. Among authors: kishi k. Circulation. 2010 Jul 6;122(1):42-51. doi: 10.1161/CIRCULATIONAHA.109.905802. Epub 2010 Jun 21. Circulation. 2010. PMID: 20566954
The potential benefits and risks of the use of dual antiplatelet therapy beyond 6 months following sirolimus-eluting stent implantation for low-risk patients.
Nakagawa T, Hiasa Y, Hosokawa S, Minami T, Yano Y, Yoneda K, Mizobe M, Murakami N, Tobetto Y, Chen H, Miyazaki S, Mahara K, Ogura R, Miyajima H, Yuba K, Takahashi T, Kishi K, Ohtani R. Nakagawa T, et al. Among authors: kishi k. J Cardiol. 2011 May;57(3):283-9. doi: 10.1016/j.jjcc.2011.02.005. Epub 2011 Mar 22. J Cardiol. 2011. PMID: 21429711 Free article.
Sirolimus-eluting stent implantation for ostial left anterior descending coronary artery lesions: three-year outcome from the j-Cypher Registry.
Kishi K, Kimura T, Morimoto T, Namura M, Muramatsu T, Nishikawa H, Hiasa Y, Isshiki T, Nobuyoshi M, Mitsudo K; j-Cypher Registry Investigators. Kishi K, et al. Circ Cardiovasc Interv. 2011 Aug;4(4):362-70. doi: 10.1161/CIRCINTERVENTIONS.111.961904. Epub 2011 Jun 28. Circ Cardiovasc Interv. 2011. PMID: 21712527 Free article.
Three-year outcome of sirolimus-eluting stent implantation in coronary bifurcation lesions: the provisional side branch stenting approach versus the elective two-stent approach.
Tamura T, Kimura T, Morimoto T, Nakagawa Y, Furukawa Y, Kadota K, Tatami R, Kawai K, Sone T, Miyazaki S, Mitsudo K; j-Cypher Registry Investigators. Tamura T, et al. EuroIntervention. 2011 Sep;7(5):588-96. doi: 10.4244/EIJV7I5A95. EuroIntervention. 2011. PMID: 21930463 Free article.
Impact of angiographic peri-stent contrast staining (PSS) on late adverse events after sirolimus-eluting stent implantation: an observation from the multicenter j-Cypher registry PSS substudy.
Imai M, Kimura T, Morimoto T, Saito N, Shiomi H, Kawaguchi R, Kan H, Mukawa H, Fujita H, Ishise T, Hayashi F, Nagao K, Take S, Taniguchi H, Sakamoto H, Yamane T, Shirota K, Tamekiyo H, Okamura T, Kishi K, Miyazaki S, Yamamoto S, Yamaji K, Kawasaki T, Taguchi E, Nakajima H, Kosedo I, Tada T, Kadota K, Mitsudo K. Imai M, et al. Among authors: kishi k. Cardiovasc Interv Ther. 2014 Jul;29(3):226-36. doi: 10.1007/s12928-014-0248-6. Epub 2014 Feb 15. Cardiovasc Interv Ther. 2014. PMID: 24532230
Outcomes of Percutaneous Coronary Interventions for Chronic Total Occlusion Performed by Highly Experienced Japanese Specialists: The First Report From the Japanese CTO-PCI Expert Registry.
Suzuki Y, Tsuchikane E, Katoh O, Muramatsu T, Muto M, Kishi K, Hamazaki Y, Oikawa Y, Kawasaki T, Okamura A. Suzuki Y, et al. Among authors: kishi k. JACC Cardiovasc Interv. 2017 Nov 13;10(21):2144-2154. doi: 10.1016/j.jcin.2017.06.024. Epub 2017 Oct 18. JACC Cardiovasc Interv. 2017. PMID: 29055764 Free article.
Randomized comparison between 2-link cell design biolimus A9-eluting stent and 3-link cell design everolimus-eluting stent in patients with de novo true coronary bifurcation lesions: the BEGIN trial.
Yamawaki M, Muramatsu T, Ashida K, Kishi K, Morino Y, Kinoshita Y, Fujii T, Noguchi Y, Hosogi S, Kawai K, Hibi K, Shibata Y, Ohira H, Morita Y, Tarutani Y, Toda M, Shimada Y, Ikari Y, Ando J, Hikichi Y, Otsuka Y, Fuku Y, Ito S, Katoh H, Kadota K, Ito Y, Mitsudo K. Yamawaki M, et al. Among authors: kishi k. Heart Vessels. 2019 Aug;34(8):1297-1308. doi: 10.1007/s00380-019-01368-3. Epub 2019 Mar 11. Heart Vessels. 2019. PMID: 30859377 Clinical Trial.
1,952 results